Abstract:To explore the potential of the swinepox virus (SPV) as vector for Streptococcus suis vaccines, a vector system was developed for the construction of a recombinant SPV carrying bacterial genes. Using this system, a recombinant virus expressing truncated muramidase-released protein (MRP) of S. suis type 2 (SS2), designated rSPV-MRP, was produced and identified by PCR, western blotting and immunofluorescence assays. The rSPV-MRP was found to be only slightly attenuated in PK-15 cells, when compared with the wild-type virus. After immunization intramuscularly with rSPV-MRP, SS2 inactive vaccine (positive control), wild-type SPV (negative control) and PBS (blank control) respectively, all CD1 mice were challenged with a lethal dose or a sublethal dose of SS2 highly virulent strain ZY05719. While SS2 inactive vaccine protected all mice, immunization with rSPV-MRP resulted in 60% survival and protected mice against a lethal dose of the highly virulent SS2 strain, compared with the negative control (P < 0.05). Our data indicate that animals immunized with rSPV-MRP had a significantly reduced bacterial burden in all organs examined, compared to negative controls and blank controls (P <0.05). Antibody titers of the rSPV-MRP-vaccinated group were significantly higher (P <0.001), when compared to negative controls and blank controls. Antibody titers were also significantly higher in the vaccinated group at all time points post-vaccination (P <0.001), compared with the positive controls. These initial results demonstrated that the rSPV-MRP provided mice with protection from systemic SS2 infection. If SPV recombinants have the potential as S. suis vaccines for the use in pigs has to be evaluated in further studies.

Evaluation of the Protective Efficacy of a Newly Identified Immunogenic Protein, HP0272, of Streptococcus Suis.

Identification of a Surface Protective Antigen, HP0197 of Streptococcus Suis Serotype 2

Induction of Protective Immune Response Against Streptococcus Suis Serotype 2 Infection by the Surface Antigen HP0245.

Evaluation of the Immunogenicity and the Protective Efficacy of a Novel Identified Immunogenic Protein, SsPepO, of Streptococcus Suis Serotype 2.

Evaluation of the immunogenicity and protective ability of a pili subunit, SBP2', of Streptococcus suis serotype 2

Evaluation of the Protective Efficacy of Four Novel Identified Membrane Associated Proteins of Streptococcus Suis Serotype 2.

Identification and Characterization of Novel Immunogenic Proteins of Streptococcus Suis Serotype 2

Evaluation of the Immunoprotective Effects of IF-2 GTPase and SSU05-1022 As a Candidate for a Streptococcus Suis Subunit Vaccine

Immunogenicity and Cross-Protective Efficacy of Double-Mutant Streptococcus Suis ΔSspepO/ΔSspspC Serotypes 2 and 7.

Immunogenicity and Protective Capacity of EF-Tu and FtsZ of Streptococcus Suis Serotype 2 Against Lethal Infection.

First Insights into the Protective Effects of a Recombinant Swinepox Virus Expressing Truncated MRP of Streptococcus Suis Type 2 in Mice.

Pre-Absorbed Immunoproteomics: A Novel Method for the Detection of Streptococcus Suis Surface Proteins

Characterization of IgA1 protease as a surface protective antigen of Streptococcus suis serotype 2.

Identification and Characterization of a Novel Protective Antigen, Enolase of Streptococcus Suis Serotype 2.

Construction, Characterization And Evaluation Of The Protective Efficacy Of The Streptococcus Suis Double Mutant Strain Delta Sspep/Delta Sspspc As A Live Vaccine Candidate In Mice

Peptidyl isomerase PrsA is surface-associated on Streptococcus suis and offers cross protection against serotype 9 strain.

Immunoproteomics of Extracellular Proteins of Chinese Virulent Strains of Streptococcus Suis Type 2

Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice.

Model of Piglet Infected by Streptococcus suis Type 2 and Immune Protective Trial of Vaccine against Swine Streptococcosis

Analysis of Immune Effect on Streptococcus suis-Haemophilus parasuis Bivalent Subunit Vaccine in Mice

Identification of Immunogenic Cell Wall-Associated Proteins of Streptococcus Suis Serotype 2